| Page 2 of 2 < |
Clinical Trials Update: Jan. 12, 2007
-----
Seizure Disorders
REPORTER'S QUERY The Washington Post is looking for challenging medical cases--ones that have been resolved but in which the patient's symptoms were puzzling to doctors or suggested an immediate diagnosis that would have been wrong.
Patients must have medical records documenting their care, and must be willing to share them with a reporter. Please include day and evening phone numbers and an e-mail address. E-mail medicalmysteries@washpost.com with your name and details. Please put "Medical Mystery" in the subject line.In Depth
AIDS/HIVVirus that causes AIDS passes between U.S. and Mexico. 
Young Lives at RiskExplore the epidemic of childhood obesity, and learn what's being done to stop it. 
All About PlasticsPlastics changed our world. But are we trading safety for convenience? 
Staph InfectionsThe latest patient information on methicillin-resistant staph infections and how to avoid them.
 
Your Co-Workers Like McSteamy?
We can help you find the right work environment with competitive benefits. Nursing, Allied Health: Get a New Job
|
This study will evaluate the safety and effectiveness of the novel compound RWJ-333369 in people with partial onset seizures who are currently being treated with one or two concomitant antiepileptic drugs. Candidates must have a history of either partial onset seizure (including either complex partial or partial with secondary generalization, or both) or primarily generalized tonic-clonic seizures for at least one year, with no period of seizure freedom greater than three months in the past year in spite of prior treatment with at least two antiepileptic drugs. People with a history of drug or alcohol abuse within the past two years will not be included.
The research site is in Providence, RI.
More information
Please see http:/
-----
Copyright 2007 Thomson CenterWatch. All rights reserved.
